Commends Senator Tillis and the Senate Judiciary Subcommittee on Intellectual Property for holding hearing & shining a light on the important issue of low-quality and invalid patents. WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the following statement […]

Continue Reading

Thanks Representatives Spanberger and Reed for introducing legislation to stop the big drug companies from using patent thickets to abuse the patent system and hurt patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today in […]

Continue Reading

IN CASE YOU MISSED IT: A new report from the Kaiser Family Foundation (KFF) examines the rising cost of Medicare Part D drugs and found that Big Pharma has jacked up the price of key prescription drugs well above the rate of inflation between 2016 and 2017. Among the worst offenders, according to the KFF report, are drugs […]

Continue Reading

WHAT YOU NEED TO KNOW Thanks to the bipartisan efforts of U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), who are among those in both parties working to end Big Pharma’s exploitation of American patients, the big drug companies are on the defensive as support grows to address Big Pharma’s rampant patent abuse. On […]

Continue Reading

N CASE YOU MISSED IT: On Wednesday, Law360 published the below op-ed by intellectual property attorneys Stacie Ropka, Ted Mathias, and Chantelle Ankerman. Their op-ed highlights Big Pharma’s use of patent thickets to abuse the patent system and details how drugmaker Abbive has erected patent thickets around its best-selling drug, Humira. Humira was first licensed by the Food and […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, Axios highlighted a report from the Institute for Clinical and Economic Review (ICER), which found that drugmakers are not raising the prices on their products due to increased quality or safety, but simply because they can. For example, Humira, the world’s best-selling prescription drug, saw a $1.9 billion increase in net spending attributable […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Michael Carrier, professor of law at Rutgers Law School and Genevieve Tung, associate director of the Rutgers Law Library, published an op-ed in Stat News on September 26 debunking Big Pharma’s disingenuous opposition of reforming the patent system. The pair encourages lawmakers to stand up to Big […]

Continue Reading